EANS-Stimmrechte: AGENNIX AG / Veröffentlichung gemäß § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung

--------------------------------------------------------------------------------
Stimmrechtsmitteilung übermittelt durch euro adhoc mit dem Ziel einer
europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich.
--------------------------------------------------------------------------------

Mitteilung nach § 21 Abs. 1 WpHG (Aktie)

Koninklijke DSM N.V., Heerlen, The Netherlands
Gist-Brocades International B.V., Delft, The Netherlands

On October 27, 2010, Koninklijke DSM N.V., Heerlen, The Netherlands, informed us
pursuant to Sec. 21 para 1 WpHG that they have not taken part in the recent
increase of the statutory capital of Agennix AG by which Agennix AG issued
20,588,705 new shares. As a result, their percentage of voting rights in Agennix
AG (represented by 915,538 shares held by their fully controlled subsidiary
Gist-Brocades International B.V. and attributed to Koninklijke DSM N.V. pursuant
to Sec. 22 para 1 no. 1 WpHG) have fallen below 3% on October 4, 2010 and are as
per this date only 2.21% of the total voting rights in Agennix AG.

On October 27, 2010, Gist-Brocades International B.V., Delft, The Netherlands,
informed us pursuant to Sec. 21 para 1 WpHG that they have not taken part in the
recent increase of the statutory capital of Agennix AG by which Agennix AG
issued 20,588,705 new shares. As a result, their voting rights in Agennix AG
(represented by 915,538 shares) have fallen below 3% on October 4, 2010 and are
as per this date only 2.21% of the total voting rights in Agennix AG.

Heidelberg, October 28, 2010

Agennix AG
The Management Board (Vorstand)

Rückfragehinweis:
Investor Relations & Corporate Communications
Tel.: +49 (0) 89 8565 2693
E-Mail: [email protected]

Ende der Mitteilung euro adhoc
--------------------------------------------------------------------------------

Emittent:    AGENNIX AG
             Im Neuenheimer Feld 515
             D-69120 Heidelberg
Telefon:     +49 89 8565 2693
FAX:         +49 89 8565 2610
Email:       [email protected]
WWW:         http://www.agennix.com
Branche:     Pharma
ISIN:        DE000A1A6XX4
Indizes:     CDAX, Prime All Share, Technology All Share
Börsen:      Regulierter Markt/Prime Standard: Frankfurt, Freiverkehr: Berlin,
             Hamburg, Düsseldorf, Hannover, München 
Sprache:     Deutsch

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | OTB

print